Dubai, United Arab Emirates, December 31, 2024, PakGazette
Decentralized science (DeSci) aims to address systemic inefficiencies in traditional scientific research, such as bureaucratic funding processes, underfunded innovative opportunities, and limited retail access to longevity investments.
SUI Desci Agents, a platform that enables the retail audience to invest in advances in longevity research, is poised to become a leading project at the forefront of the next trend.
BIO Protocol Binance Listing
On December 23, 2024, Binance posted a tweet announcing the launch of the BIO Protocol launch group.
Users can now stake their BNB and FDUSD to win BIO airdrops for 10 days, with a Binance listing of the BIO Protocol scheduled for January 3, 2025.
SUI DeSci Agents at the forefront of DeSci
SUI Desci Agents is a platform to launch DeSci assets, automatically grow your audience with AI agents, and generate liquidity with mechanics inspired by pump.fun. Its goal is to democratize access to longevity research investments for retail users.
$DESCI offers a variety of features that make the project unique:
- Tokenized Compounds: Users can bet on the potential of longevity compounds like Epitalon and Rapamycin (the first compounds to be released) by reviewing their scientific data and statistics.
- Pluggable AI Agents: LLM trained AI agents are paired with longevity compounds and promote them 24/7 on social platforms ensuring efficient reach.
- Layer 2 Liquidity Mechanics: Combining $DESCI tokens with composites creates a robust liquidity ecosystem designed for DeSci.
- AI-powered B2C products: Wellness tools attract millions of health enthusiasts, driving organic growth and supporting the ecosystem.
The number of DeSci supporters continues to grow
The number of DeSci supporters continues to grow and includes prominent web3 leaders and large web2 venture capital firms:
- Vitalik Buterin emphasized the transformative potential of DeSci projects at the recent Devcon event.
- Coinbase (NASDAQ 🙂) founder Brian Armstrong backs ResearchHub to drive open scientific collaboration.
- A16Z led a $5 million funding round for AminoChain, a decentralized marketplace for biological samples.
- Pfizer (NYSE:) Ventures participated in a $4.1 million funding round for VitaDAO, a project focused on raising funds for research that extends human lifespan.
2025: The year of $DeSci
In November 2024, pump.science launched two tokens, Rifampicin and Urolitin A, which have since gained attention in the market. Their market capitalizations reached approximately $125 million and $45 million, respectively, within days of their introduction.
The decentralized science (DeSci) sector continues to expand, and SUI DeSci Agents establishes itself as a potential leader. The project is developing a platform where the retail audience can invest in tokenized longevity compounds. They are also working on AI-powered B2C wellness tools that would help SUI Desci agents bring more users into the ecosystem.
As interest in a decentralized approach to science grows, $DESCI aims to contribute to the evolution of scientific innovation.
About DeSci SUI Agents
SUI DeSci Agents is a platform designed to launch DeSci assets, grow your audience with AI agents, and create liquidity through advanced mechanics inspired by pump.fun.
Under the trading name $DeSci, the project aims to democratize access to investments in longevity research, empowering the retail public to actively participate in scientific advances.
Contactexecutive directorOlha ZubarievaSUI Desci Agents[email protected]
